Scientific Articles

177 articles

One Size Boes Not Fit All: The Impact of Primary Vaccine Container Size on Vaccine Distribution and Delivery

April 2015

Haidari LA, Wahl B, Brown ST, Privor-Dumm L, Wallman-Stokes C, Gorham K, Connor DL, Wateska AR, Schreiber B, Dicko H, Jaillard P, Avella M, Lee BY.

Vaccine. 2015 Jun 22;33(28):3242-7. doi: 10.1016/j.vaccine.2015.04.018. Epub 2015 Apr 15.

Résumé

Cost-Effectiveness of Pneumococcal Conjugate Vaccination in Georgia

May 2015

Komakhidze T, Hoestlandt C, Dolakidze T, Shakhnazarova M, Chlikadze R, Kopaleishvili N, Goginashvili K, Kherkheulidze M, Clark AD, Blau J.

Vaccine. 2015 May 7;33 Suppl 1:A219-A226. doi: 10.1016/j.vaccine.2014.12.070.

Résumé

Cost-Effectiveness of Pneumococcal Conjugate Vaccination in Croatia

May 2015

Vučina VV, Filipović SK, Kožnjak N, Stamenić V, Clark AD, Mounaud B, Blau J, Hoestlandt C, Kaić B.

Vaccine. 2015 May 7;33 Suppl 1:A209-A218. doi: 10.1016/j.vaccine.2014.12.043.

Résumé

Cost-Effectiveness of Rotavirus Vaccination in Albania

May 2015

Ahmeti A, Preza I, Simaku A, Nelaj E, Clark AD, Felix Garcia AG, Lara C, Hoestlandt C, Blau J, Bino S.

Vaccine. 2015 May 7;33 Suppl 1:A201-A208. doi: 10.1016/j.vaccine.2014.12.075.

Résumé

Cost-Effectiveness Analysis of the Introduction of Rotavirus Vaccine in Iran

May 2015

Javanbakht M, Moradi-Lakeh M, Yaghoubi M, Esteghamati A, Mansour Ghanaie R, Mahmoudi S, Shamshiri AR, Zahraei SM, Baxter L, Shakerian S, Chaudhri I, Fleming JA, Munier A, Baradaran HR.

Vaccine. 2015 May 7;33 Suppl 1:A192-A200. doi: 10.1016/j.vaccine.2014.12.035.

Résumé

Cost-Effectiveness Analysis of the Introduction of the Pneumococcal Conjugate Vaccine (PCV-13) in the Egyptian National Immunization Program 2013

May 2015

Sibak M, Moussa I, El-Tantawy N, Badr S, Chaudhri I, Allam E, Baxter L, Abo Freikha S, Hoestlandt C, Lara C, Hajjeh R, Munier A.

Vaccine. 2015 May 7;33 Suppl 1:A182-A191. doi: 10.1016/j.vaccine.2014.12.044.

Résumé

Strengthening National Decision-Making on Immunization by Building Capacity for Economic Evaluation: Implementing ProVac in Europe

May 2015

Blau J, Hoestlandt C, D Clark A, Baxter L, Felix Garcia AG, Mounaud B, Mosina L.

Vaccine. 2015 May 7;33 Suppl 1:A34-A39. doi: 10.1016/j.vaccine.2014.12.073.

Résumé

Evidence-Based Decision-Making for Vaccine Introductions: Overview of the ProVac International Working Group's Experience

May 2015

Jauregui B, Garcia AG, Bess Janusz C, Blau J, Munier A, Atherly D, Mvundura M, Hajjeh R, Lopman B, Clark AD, Baxter L, Hutubessy R, de Quadros C, Andrus JK.

Vaccine. 2015 May 7;33 Suppl 1:A28-A33. doi: 10.1016/j.vaccine.2014.10.090.

Résumé

Design of a Phase III Cluster Randomized Trial to Assess the Efficacy and Safety of a Malaria Transmission Blocking Vaccine

February 2015

Delrieu I, Leboulleux D, Ivinson K, Gessner BD; Malaria Transmission Blocking Vaccine Technical Consultation Group.

Vaccine. 2015 Mar 24;33(13):1518-1526. doi: 10.1016/j.vaccine.2015.01.050. Epub 2015 Feb 10.

Résumé

En eaux troubles : incertitudes et vulnérabilité sociale des pêcheurs piroguiers face au choléra

October 2014

Léonard Heyerdahl

In troubled waters

Résumé